BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Fadrozole

A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.

300+ PubMed studies analyzed · 11 RCTs · Evidence Score: 39.9

Research Domains

Fadrozole has been studied across 20 research domains including 🧬 Hormones, ♀♂ Sexual Health, 💪 Strength & Power, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🧬 Hormones with 58% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fadrozole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

osilodrostat
3 shared targets
dexfadrostat
3 shared targets
s
3 shared targets
metyrapone
2 shared targets
azalanstat
2 shared targets
benzylimidazole
3 shared targets
Letrozole
3 shared targets
abiraterone
2 shared targets
Butaclamol
2 shared targets
Tomatine
2 shared targets
Loading evidence profile...

This evidence profile for Fadrozole is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.